» Articles » PMID: 31576144

LINC00565 Promotes Proliferation and Inhibits Apoptosis of Gastric Cancer by Targeting MiR-665/AKT3 Axis

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2019 Oct 3
PMID 31576144
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Numerous studies have shown that long noncoding RNA (lncRNA) is involved in gastric cancer (GC). A relevant microarray containing gastric cancer-related lncRNAs was downloaded from The Cancer Genome Atlas database.

Methods: qRT-PCR was used to analyze LINC00565 and AKT3 expression in tumor tissues and cell lines. Proliferative, colony formation and apoptotic abilities of GC cells after transfection of sh-LINC00565 were determined by CCK-8, colony formation assay and flow cytometry, respectively. RIP was enrolled to detect the interaction between LINC00565, AKT3 and miR-665. Dual luciferase assay was used to confirm the relation between miR-665 and LINC00565 and AKT3.

Results: Expression level of LINC00565 in GC tissue was highly expressed in GC, which was negatively correlated to prognosis of GC patients. The results showed that knockdown of LINC00565 decreased proliferative and colony formation abilities, and induced apoptosis of GC cells. Pearson analysis showed that LINC00565 was positively correlated with AKT3. Besides, AKT3 was significantly up-regulated in GC. In addition, knockdown of LINC00565 down-regulated AKT3. In order to explore the mechanism, we found that miR-665 could bind to LINC00565 by bioinformatics. Dual-luciferase reporter gene assay and RIP assay both verified the binding relationship between miR-665 and AKT3. Finally, rescue experiments were carried out to explore whether AKT3 could reverse the anti-cancer effect of low-level LINC00565 on GC development.

Conclusion: In summary, the expression of LINC00565 is upregulated in GC. LINC00565 can be used as the sponge of miR-665 to up-regulate the expression of AKT3, thus promoting the progression of GC.

Citing Articles

Hsa-miR-665 Is a Promising Biomarker in Cancer Prognosis.

Guan X, Pavani K, Chunduru J, Broeckx B, Van Soom A, Peelman L Cancers (Basel). 2023; 15(20).

PMID: 37894282 PMC: 10605552. DOI: 10.3390/cancers15204915.


Clinicopathological and prognostic value of long non-coding RNA CCAT1 expression in patients with digestive system cancer.

Yu Y, Xu Z, Ni H, Jin M, Dai C Oncol Lett. 2023; 25(2):73.

PMID: 36688111 PMC: 9843303. DOI: 10.3892/ol.2023.13659.


Construction of a cuproptosis-related lncRNA signature for predicting prognosis and immune landscape in osteosarcoma patients.

Ni S, Hong J, Li W, Ye M, Li J Cancer Med. 2022; 12(4):5009-5024.

PMID: 36129020 PMC: 9972154. DOI: 10.1002/cam4.5214.


LncRNA RPSAP52 promotes cell proliferation and inhibits cell apoptosis via modulating miR-665/STAT3 in gastric cancer.

He C, Liu Y, Li J, Zheng X, Liang J, Cui G Bioengineered. 2022; 13(4):8699-8711.

PMID: 35322746 PMC: 9161851. DOI: 10.1080/21655979.2022.2054754.


Long Noncoding RNA Mediated Regulation in Human Embryogenesis, Pluripotency, and Reproduction.

Liu L, Fang F Stem Cells Int. 2022; 2022:8051717.

PMID: 35103065 PMC: 8800634. DOI: 10.1155/2022/8051717.


References
1.
Chin Y, Yoshida T, Marusyk A, Beck A, Polyak K, Toker A . Targeting Akt3 signaling in triple-negative breast cancer. Cancer Res. 2013; 74(3):964-73. PMC: 3946502. DOI: 10.1158/0008-5472.CAN-13-2175. View

2.
Zeng Z, Luo F, Zou L, He R, Pan D, Chen X . Human papillomavirus as a potential risk factor for gastric cancer: a meta-analysis of 1,917 cases. Onco Targets Ther. 2016; 9:7105-7114. PMC: 5119622. DOI: 10.2147/OTT.S115053. View

3.
Berretta J, Morillon A . Pervasive transcription constitutes a new level of eukaryotic genome regulation. EMBO Rep. 2009; 10(9):973-82. PMC: 2750061. DOI: 10.1038/embor.2009.181. View

4.
Moran V, Perera R, Khalil A . Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res. 2012; 40(14):6391-400. PMC: 3413108. DOI: 10.1093/nar/gks296. View

5.
Zhou B, Guo W, Sun C, Zhang B, Zheng F . Linc00462 promotes pancreatic cancer invasiveness through the miR-665/TGFBR1-TGFBR2/SMAD2/3 pathway. Cell Death Dis. 2018; 9(6):706. PMC: 5999603. DOI: 10.1038/s41419-018-0724-5. View